Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 418

1.

Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era.

Onda T, Inoue K, Suwa S, Nishizaki Y, Kasai T, Kimura Y, Fukuda K, Okai I, Fujiwara Y, Matsuoka J, Sumiyoshi M, Daida H.

Int J Cardiol. 2016 Jun 14;219:180-185. doi: 10.1016/j.ijcard.2016.06.014. [Epub ahead of print]

PMID:
27327504
2.

Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.

Christensen MK, Huang H, Torp-Pedersen C, Trydal T, Ravkilde J.

BMC Cardiovasc Disord. 2016 Jun 16;16:140. doi: 10.1186/s12872-016-0293-4.

3.

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.

Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Bellomo G, Marino P, Suryapranata H, De Luca G.

Neth Heart J. 2016 Jun 8. [Epub ahead of print]

PMID:
27277659
4.

Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?

Khurelsukh K, Kim YH, Seon HJ, Song JH, Park SY, Moon SM, Kim SH, Sim DS, Ahn Y.

Int J Cardiovasc Imaging. 2016 May 2. [Epub ahead of print]

PMID:
27139462
5.

Older coronary thrombus is an independent predictor of 1-year mortality in acute myocardial infarction.

Li X, Kramer MC, Damman P, van der Wal AC, Grundeken MJ, van Straalen JP, Koch KT, Henriques JP, Baan J Jr, Vis MM, Piek JJ, Fischer JC, Tijssen JG, de Winter RJ.

Eur J Clin Invest. 2016 Jun;46(6):501-10. doi: 10.1111/eci.12619. Epub 2016 Apr 15.

PMID:
26988709
6.

Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.

Hueb W, Gersh BJ, Alves da Costa LM, Costa Oikawa FT, Vieira de Melo RM, Rezende PC, Garzillo CL, Lima EG, Nomura CH, Villa AV, Hueb AC, Cassaro Strunz CM, Favarato D, Takiuti ME, de Albuquerque CP, Ribeiro da Silva EE, Franchini Ramires JA, Kalil Filho R.

Ann Thorac Surg. 2016 Jun;101(6):2202-8. doi: 10.1016/j.athoracsur.2015.11.034. Epub 2016 Feb 22.

PMID:
26912303
7.

Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.

Mehta V, Sukhija R, Mehra P, Goyal A, Yusuf J, Mahajan B, Gupta VK, Tyagi S, Palaniswamy C, Aronow WS.

Indian Heart J. 2016 Jan-Feb;68(1):57-62. doi: 10.1016/j.ihj.2015.06.034. Epub 2016 Jan 18.

8.

Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention.

Karataş MB, Çanga Y, Özcan KS, İpek G, Güngör B, Onuk T, Durmuş G, Öz A, Karaca M, Bolca O.

Am J Emerg Med. 2016 Feb;34(2):240-4. doi: 10.1016/j.ajem.2015.10.049. Epub 2015 Oct 27.

PMID:
26585199
9.

Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.

Leibundgut G, Gick M, Morel O, Ferenc M, Werner KD, Comberg T, Kienzle RP, Buettner HJ, Neumann FJ.

Clin Res Cardiol. 2016 May;105(5):432-40. doi: 10.1007/s00392-015-0938-9. Epub 2015 Nov 12.

PMID:
26563201
10.

[Clinical Impact of High Sensitive Troponin I Assay].

Sugawa S, Sawano K.

Rinsho Byori. 2015 Jan;63(1):53-61. Review. Japanese.

PMID:
26524879
11.

High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.

Reinstadler SJ, Feistritzer HJ, Klug G, Mair J, Tu AM, Kofler M, Henninger B, Franz WM, Metzler B.

Int J Cardiol. 2016 Jan 1;202:188-93. doi: 10.1016/j.ijcard.2015.09.001. Epub 2015 Sep 6.

PMID:
26397408
12.

Comparison of Changes in Global Longitudinal Peak Systolic Strain After ST-Segment Elevation Myocardial Infarction in Patients With Versus Without Diabetes Mellitus.

Hoogslag GE, Abou R, Joyce E, Boden H, Kamperidis V, Regeer MV, van Rosendael PJ, Schalij MJ, Bax JJ, Marsan NA, Delgado V.

Am J Cardiol. 2015 Nov 1;116(9):1334-9. doi: 10.1016/j.amjcard.2015.07.061. Epub 2015 Aug 14.

PMID:
26341185
13.

Circulating MicroRNA-146a and MicroRNA-21 Predict Left Ventricular Remodeling after ST-Elevation Myocardial Infarction.

Liu X, Dong Y, Chen S, Zhang G, Zhang M, Gong Y, Li X.

Cardiology. 2015;132(4):233-41.

PMID:
26337652
14.

Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial.

Ghaeli P, Vejdani S, Ariamanesh A, Hajhossein Talasaz A.

Iran J Pharm Res. 2015 Summer;14(3):851-5.

15.

Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.

Deftereos S, Giannopoulos G, Angelidis C, Alexopoulos N, Filippatos G, Papoutsidakis N, Sianos G, Goudevenos J, Alexopoulos D, Pyrgakis V, Cleman MW, Manolis AS, Tousoulis D, Lekakis J.

Circulation. 2015 Oct 13;132(15):1395-403. doi: 10.1161/CIRCULATIONAHA.115.017611. Epub 2015 Aug 11.

PMID:
26265659
16.

Late diagnosis of Wellens syndrome in a patient presenting with an atypical acute coronary syndrome.

Venkatesan R, Methachittiphan N, Berbarie RF, Aaron E, Jaffery Z, Rangasetty U.

Am J Emerg Med. 2016 Feb;34(2):338.e3-5. doi: 10.1016/j.ajem.2015.06.018. Epub 2015 Jun 12. No abstract available.

PMID:
26265400
17.

Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.

Ishibashi Y, Muramatsu T, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Cho YK, Garcia-Garcia HM, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, McClean D, de Sousa Almeida M, Wasungu L, Miquel-Hebert K, Dudek D, Chevalier B, Onuma Y, Serruys PW.

JACC Cardiovasc Interv. 2015 Jul;8(8):1053-63. doi: 10.1016/j.jcin.2015.06.001.

PMID:
26205444
18.

ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.

Hishikari K, Kakuta T, Lee T, Murai T, Yonetsu T, Isobe M.

Catheter Cardiovasc Interv. 2016 Mar;87(4):E113-21. doi: 10.1002/ccd.26072. Epub 2015 Jul 8.

PMID:
26152334
19.

Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.

Kini AS, Motoyama S, Vengrenyuk Y, Feig JE, Pena J, Baber U, Bhat AM, Moreno P, Kovacic JC, Narula J, Sharma SK.

JACC Cardiovasc Interv. 2015 Jun;8(7):937-45. doi: 10.1016/j.jcin.2015.03.016.

20.

The role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction.

Kirbiš S, Gorenjak M, Sinkovič A.

BMC Cardiovasc Disord. 2015 Jun 13;15:49. doi: 10.1186/s12872-015-0054-9.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk